The first one was CD5−/CD10+ and large-sized (based on the forward scatter), accounting for approximately 18% of lymphoma cells, and the second subpopulation was CD5+/CD10− and small-sized (based on the forward scatter), accounting for approximately 82% of lymphoma cells. This evidence concerns the gene CD5 and lymphoma.